Skip to main content
. 2020 Oct 26;5(1):88–92. doi: 10.1016/j.jseint.2020.09.001

Table I.

Analysis of risk factors, concomitant procedures, and incidence of shoulder stiffness distributed by follow-up visit

Risk factor Time point 4 (12 weeks)
Time point 5 (16-24 weeks)
Time point 6 (52 weeks)
Stiff Not stiff P value Stiff Not stiff P value Stiff Not stiff P value
Age, mean (SD), yr 58.2 (8.5) 57.4 (7.3) .74 51.8 (7.3) 57.6 (7.3) .12 50.5 (12.0) 57.6 (7.3) .18
Sex, n (%)
 Female 5 (55.6) 38 (32.5) .27 3 (75.0) 40 (32.8) .11 2 (100.0) 41 (33.1) .11
 Male 4 (44.44) 79 (67.5) 1 (25.0) 82 (67.2) 0 (0.0) 83 (66.9)
Hyperlipidemia, n (%)
 Yes 1 (11.1) 26 (22.2) .68 1 (25.0) 26 (21.3) >.99 1 (50.0) 26 (21.0) .38
 No 8 (77.8) 91 (77.8) 3 (75.0) 96 (78.7) 1 (50.0) 98 (79.0)
Hypertension, n (%)
 Yes 3 (33.3) 35 (29.9) >.99 2 (50.0) 36 (29.5) .58 1 (50.0) 37 (29.8) .51
 No 6 (66.7) 82 (70.1) 2 (50.0) 86 (70.5) 1 (50.0) 87 (70.2)
Workers’ compensation insurance, n (%)
 Yes 3 (33.3) 29 (24.8) .69 1 (25.0) 31 (25.4) >.99 0 (0.0) 32 (25.8) >.99
 No 6 (66.7) 88 (75.2) 3 (75.0) 91 (74.6) 2 (100.0) 92 (74.2)
Subacromial decompression, n (%)
 Yes 6 (66.7) 82 (70.1) >.99 2 (50.0) 86 (29.5) .58 1 (50.0) 87 (70.2) .51
 No 3 (33.3) 35 (29.9) 2 (50.0) 36 (70.5) 1 (50.0) 37 (29.8)
Débridement, n (%)
 Yes 2 (22.2) 25 (21.4) >.99 1 (25.0) 26 (21.3) >.99 0 (0.0) 27 (21.8) >.99
 No 7 (77.8) 92 (78.6) 3 (75.0) 96 (78.7) 2 (100.0) 97 (78.2)
Biceps tenotomy or tenodesis, n (%)
 Yes 5 (55.6) 29 (24.8) .06 2 (50.0) 32 (26.2) .29 1 (50.0) 33 (26.6) .47
 No 4 (44.4) 88 (75.2) 2 (50.0) 90 (73.8) 1 (50.0) 91 (73.4)
Total, n (%) 9 (7.1) 117 (92.9) 4 (3.2) 122 (96.8) 2 (1.6) 124 (98.4)

SD, standard deviation.

Stiffness was defined as total range of motion between passive forward flexion and abducted external rotation ≤ 220°.